Plasma Treatment Works For COVID-19 Patients: Mayo Clinic Study
Blood plasma transfusions containing high levels of COVID-19 antibodies reduced deaths in some virus patients and gave credibility to one of the few known treatments for the disease, according to a new study conducted by researchers at the Mayo Clinic.
“The early administration of high-titer convalescent plasma against SARS-CoV-2 to slightly ill infected older adults reduced the progression of Covid-19,” the researchers concluded.
The study was published on Wednesday in the New England Journal of Medicine, along with an editorial titled “(A Little) Clarity on Convalescent Plasma for Covid-19,” which explains how the treatment works.
“I think it is up to the medical community to keep innovating and testing therapies for treatment. Realistically, we are months away from having a significant number of people vaccinated, ”said Dr. R. Scott Wright, Mayo Clinic’s COVID-19 Plasma Therapy Program Coordinator, told the Minneapolis Star-Tribune.
Patients who were given antibody-rich plasma for the first three days of treatment had better results, but the treatment was less effective in patients who were treated for longer and required ventilation.
“Patients who were ventilated saw no benefit,” said Dr. Wright of the Star Tribune. “It was too late.”
The study looked at 3,082 patients and found that patients who received antibody-rich plasma were 25% less likely to die.
Thank You For Visiting. Please Support This Site By SHARING And Following Us In The Social Networks.